Laetitia Vanwonterghem
Grenoble, 38000, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Monomer Versus Dimer of Cationic Ir(III) Complexes for Photodynamic Therapy by Two-Photon Activation: A Comparative Study.
Journal: ACS applied bio materials
Published: April 24, 2025
Self-Assembled Peptide-Gold Nanoclusters with SiRNA Targeting Telomeric Response to Enhance Radiosensitivity in Lung Cancer Cells.
Journal: Small science
Published: April 05, 2024
Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma.
Journal: The Journal of investigative dermatology
Published: May 04, 2023
Targeting Tn-Antigen-Positive Human Tumors with a Recombinant Human Macrophage Galactose C-Type Lectin.
Journal: Molecular pharmaceutics
Published: December 20, 2021
A large scale proteome analysis of the gefitinib primary resistance overcome by KDAC inhibition in KRAS mutated adenocarcinoma cells overexpressing amphiregulin.
Journal: Journal of proteomics
Published: December 05, 2018
The pyrrolopyrimidine colchicine-binding site agent PP-13 reduces the metastatic dissemination of invasive cancer cells in vitro and in vivo.
Journal: Biochemical pharmacology
Published: October 11, 2018
Design of RGD-ATWLPPR peptide conjugates for the dual targeting of αVβ3 integrin and neuropilin-1.
Journal: Organic & biomolecular chemistry
Published: May 19, 2018
Anti-tumor efficacy of hyaluronan-based nanoparticles for the co-delivery of drugs in lung cancer.
Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: October 11, 2017
Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.
Journal: Scientific reports
Published: March 22, 2017
Last Updated: 09/26/2026